Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2005
11/02/2005EP1591443A1 Pyrazole derivative
11/02/2005EP1590358A1 9-ketospinosyn derivatives
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590336A2 Substituted pyrazoles, compositions containing such compounds and methods of use
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1427415A4 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
11/02/2005EP1383749B1 Arylsulfonamides as antiviral agents
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005CN1692111A N-heteroarylnicotinamide derivatives
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1691944A Oxadiazoles as modulators of metabotropic glutamate receptor-5
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225462C New piperazine and piperidine compounds
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960575 Thiazine derivatives
11/01/2005CA2177586C 4-benzoylisoxazoles and their use as herbicides
10/2005
10/27/2005WO2005100347A1 Methods for minimizing thioamide impurities
10/27/2005WO2005100346A1 Thioamide derivatives as progesterone receptor modulators
10/27/2005WO2005100341A1 2-aminopyridine derivative
10/27/2005WO2005099709A2 Bicyclic heterocycles useful as serine protease inhibitors
10/27/2005WO2005099353A2 A novel process for the preparation of linezolid and related compounds
10/27/2005WO2005061491A3 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors
10/27/2005WO2005034848A3 Inhibitors of cathepsin s
10/27/2005WO2005021515B1 Inhibitors of phosphodiesterase type-iv
10/27/2005WO2004048330A8 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
10/27/2005US20050239869 calcium atorvastatin (Lipitor) intermediate; from intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation (patent indexing)
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239857 Novel imidazoles
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239841 New compounds
10/27/2005US20050239801 Novel compounds
10/27/2005US20050239800 Polycyclic pyrazines as potassium ion channel modulators
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239782 Arylindenopyridines and related therapeutic and prophylactic methods
10/27/2005US20050239779 Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239771 Respiratory syncytial virus replication inhibitors
10/27/2005US20050239769 Therapeutic compounds for treating dyslipidemic conditions
10/27/2005US20050239751 e.g. tert-Butyl 6-(2-(3-(2,6-Dichlorophenyl)isoxazol-5-yl)pyridin-4-ylamino)-2-methyl-4-oxohexan-3-ylcarbamate; Hepatitis C virus (HCV) infections
10/27/2005US20050239096 via unsymmetrical cyanine dyes that are derivatives of thiazole orange, staining solution and select fluorogenic compounds that are characterized as non-genotoxic; low cost
10/27/2005DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use
10/27/2005CA2562602A1 2-aminopyridine derivative
10/27/2005CA2561014A1 Thioamide derivatives as progesterone receptor modulators
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1588145A2 Methods, mixtures, kits and compositions pertaining to analyte determination
10/26/2005EP1587804A1 Androgen receptor antagonists
10/26/2005EP1587799A1 Benzoxazole derivatives and their use as adenosine receptor ligands
10/26/2005EP1587787A1 Viral polymerase inhibitors
10/26/2005EP1587509A2 Androgen receptor antagonists
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1688573A Pyrrole based inhibitors of glycogen synthase kinase 3
10/26/2005CN1688365A Therapeutic use
10/26/2005CN1687061A Compound of isobioquin group and application thereof
10/25/2005US6958396 8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-methyl-4H-Benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site
10/25/2005US6958356 Guanidine mimics factor Xa inhibitors
10/25/2005US6958355 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
10/25/2005US6958354 Pyrazole compounds as transforming growth factor (TGF) inhibitors
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958350 Chemical compounds
10/25/2005US6958348 Side effect reduction
10/25/2005US6958340 such as N-[3-methyl-5-(trifluoromethyl)phenyl]-4-(2-phenyl-1H-imidazol-1-yl)pyrimidin-2-amine; treating breast cancer; use in combination with estrogen receptor modulators such as tamoxifen and raloxifene
10/25/2005US6958339 Pyrazole derivative
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2261725C Piperidine and piperazine derivatives and their use as muscarinic antagonists
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097788A2 Sulfonamides and uses thereof
10/20/2005WO2005097786A1 Oxadiazolone derivatives as ppar delta agonists
10/20/2005WO2005097785A1 Novel diazine derivatives, their manufacture and use as pharmaceutical agents
10/20/2005WO2005097784A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005WO2005097783A1 Thiocarbamoylprolines
10/20/2005WO2005097782A1 Piperidine derivative
10/20/2005WO2005097778A1 Tetrahydrobenzazepines as histamine h3 receptor ligands
10/20/2005WO2005097777A1 New process for the preparation of diazine derivatives
10/20/2005WO2005097774A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/20/2005WO2005097765A1 Anaplastic lymphoma kinase modulators and methods of use
10/20/2005WO2005097763A2 1,3,4-oxadiazol-2-ones as ppar delta
10/20/2005WO2005097762A2 1,3,4-oxadiazol-2-ones as ppar delta modulators
10/20/2005WO2005097760A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
10/20/2005WO2005097751A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
10/20/2005WO2005097750A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097740A1 Histamine h3 receptor agents, preparation and therapeutic uses
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005097136A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005WO2005097128A1 1,4-bis-n-oxide azaanthracenediones and the use thereof
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 647